ProfileGDS4718 / 225806_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 23% 5% 71% 23% 27% 80% 84% 24% 9% 25% 34% 17% 59% 85% 87% 52% 32% 91% 84% 84% 28% 37% 27% 41% 61% 80% 26% 89% 16% 82% 76% 86% 7% 33% 83% 81% 85% 13% 13% 73% 21% 77% 90% 92% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.2718123
GSM549102patient 115, normal, homogenized [OPG study]3.570085
GSM549104patient 119, normal, homogenized [OPG study]7.046971
GSM549108patient 138, normal, homogenized [OPG study]4.3020223
GSM549119patient 077, normal, homogenized [OPG study]4.4126227
GSM549133patient 032, cancer, homogenized [OPG study]7.96980
GSM549139patient 042, cancer, homogenized [OPG study]8.3161184
GSM549099patient 107, normal, homogenized [OPG study]4.3085624
GSM549109patient 139, normal, homogenized [OPG study]3.777539
GSM549110patient 046, normal, homogenized [OPG study]4.3233925
GSM549114patient 063, normal, homogenized [OPG study]4.6550634
GSM549122patient 082, normal, homogenized [OPG study]4.0382617
GSM549134patient 033, cancer, homogenized [OPG study]6.0427759
GSM549136patient 036, cancer, homogenized [OPG study]8.5378185
GSM549140patient 044, cancer, homogenized [OPG study]8.8026787
GSM549111patient 047, normal, homogenized [OPG study]5.6385952
GSM549113patient 057, normal, homogenized [OPG study]4.5524132
GSM549132patient 031, cancer, homogenized [OPG study]9.3202391
GSM549137patient 038, cancer, homogenized [OPG study]8.3424284
GSM549142patient 047, cancer, homogenized [OPG study]7.9582484
GSM549100patient 110, normal, homogenized [OPG study]4.4716128
GSM549107patient 135, normal, homogenized [OPG study]4.8252437
GSM549115patient 068, normal, homogenized [OPG study]4.3664727
GSM549116patient 072, normal, homogenized [OPG study]5.0037341
GSM549120patient 078, normal, homogenized [OPG study]6.1806761
GSM549131patient 030, cancer, homogenized [OPG study]7.9894680
GSM549118patient 074, normal, homogenized [OPG study]4.3853926
GSM549129patient 027, cancer, homogenized [OPG study]8.9274789
GSM549123patient 088, normal, homogenized [OPG study]3.9795916
GSM549124patient 006, cancer, homogenized [OPG study]8.027582
GSM549126patient 015, cancer, homogenized [OPG study]7.4055476
GSM549128patient 025, cancer, homogenized [OPG study]8.654686
GSM549103patient 117, normal, homogenized [OPG study]3.691887
GSM549117patient 073, normal, homogenized [OPG study]4.6513733
GSM549138patient 041, cancer, homogenized [OPG study]8.2181883
GSM549141patient 045, cancer, homogenized [OPG study]8.1477281
GSM549130patient 028, cancer, homogenized [OPG study]8.3519985
GSM549101patient 111, normal, homogenized [OPG study]3.9070213
GSM549105patient 128, normal, homogenized [OPG study]3.9000713
GSM549106patient 134, normal, homogenized [OPG study]7.304973
GSM549112patient 048, normal, homogenized [OPG study]4.1765621
GSM549125patient 011, cancer, homogenized [OPG study]7.539877
GSM549127patient 024, cancer, homogenized [OPG study]9.1362790
GSM549135patient 035, cancer, homogenized [OPG study]9.5480192